Hemochromatosis News and Research

RSS
Hemochromatosis is the most common form of iron overload disease. Primary hemochromatosis, also called hereditary hemochromatosis, is an inherited disease. Secondary hemochromatosis is caused by anemia, alcoholism, and other disorders.
Researchers identify key hormone critical for preventing spread of bacterial pneumonia

Researchers identify key hormone critical for preventing spread of bacterial pneumonia

Mildly elevated body iron contributes to prevalence and incidence of type 2 diabetes

Mildly elevated body iron contributes to prevalence and incidence of type 2 diabetes

Minihepcidins may potentially treat serious genetic blood diseases in children, adults

Minihepcidins may potentially treat serious genetic blood diseases in children, adults

Invitae announces dramatic expansion of genetic testing menu

Invitae announces dramatic expansion of genetic testing menu

CLDF collaborates with Walgreens to offer free rapid HCV testing

CLDF collaborates with Walgreens to offer free rapid HCV testing

Minihepcidin reverses iron overload of hemochromatosis, stops susceptibility to infections

Minihepcidin reverses iron overload of hemochromatosis, stops susceptibility to infections

People with iron overload disease are more vulnerable to Vibrio vulnificus infections

People with iron overload disease are more vulnerable to Vibrio vulnificus infections

Keryx Biopharmaceuticals supplies AURYXIA tablets to wholesalers in US

Keryx Biopharmaceuticals supplies AURYXIA tablets to wholesalers in US

FDA approves Ferric Citrate for control of serum phosphorus levels in CKD patients on dialysis

FDA approves Ferric Citrate for control of serum phosphorus levels in CKD patients on dialysis

Argininosuccinic aciduria (ASA) and gene therapy: an interview with Dr Julien Baruteau, UCL Institute for Women's Health, London

Argininosuccinic aciduria (ASA) and gene therapy: an interview with Dr Julien Baruteau, UCL Institute for Women's Health, London

NAFLD is an independent predictor of cardiovascular risk

NAFLD is an independent predictor of cardiovascular risk

Two studies shed light on molecular biology of three blood disorders

Two studies shed light on molecular biology of three blood disorders

Researchers to develop new diagnostic tools and treatments for people with rare diseases

Researchers to develop new diagnostic tools and treatments for people with rare diseases

Liver transplantations for NASH-Cirrhosis increase dramatically

Liver transplantations for NASH-Cirrhosis increase dramatically

Cancer researchers create catalog of possible targets for new treatments

Cancer researchers create catalog of possible targets for new treatments

Public health officials should address needs of people with blood disorders

Public health officials should address needs of people with blood disorders

Scientists identify 28 blood pressure-associated genetic variants

Scientists identify 28 blood pressure-associated genetic variants

FDA clears Resonance Health's MRI-Q System for cardiac T2* iron assessment

FDA clears Resonance Health's MRI-Q System for cardiac T2* iron assessment

Xenon founder receives Canada Wightman Award for leadership in medical science

Xenon founder receives Canada Wightman Award for leadership in medical science

Hepcidin hormone may be potential therapeutic tool for anemic blood disorders

Hepcidin hormone may be potential therapeutic tool for anemic blood disorders

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.